Bolivia distributor to visit SensoDetect in Sweden
SensoDetect is discussing a collaboration with one of Bolivia's major distributors. The Distributor has contacted SensoDetect regarding cooperation during last year and a first meeting and presentation took place at the beginning of the year in Bolivia. After dialogue during the spring and summer the Distributor will now visit Sweden for further talks.
The Bolivian market is slightly larger than the Swedish based on just over 11 million inhabitants. The market for health care and Psychiatry are largely private in Bolivia, which, according to the Distributor's greatly simplifies the process of getting new products to market. The Distributor points out that interest is great for new apparatus that simplifies and streamlines the work for the hard-pressed doctors and psychiatrists in the country. The Distributor points to opportunities to collaborate with universities and hospitals in Bolivia based on existing relationships and as a result of Sensodetects visit earlier this year.
"Bolivia is an interesting market and a possible bridge to the much larger South American market. The current Distributor is a large and well-known actor in Bolivia. They represents today a number of large and well-known med-tech companies which is a definite advantage and build trust. I very much look forward to their visits and a further dialogue. We will update the market on further steps in the business ", says CEO, Johan Olson
"To expand overseas is a natural and important part of the ongoing process of change within SensoDetect. Bolivia is not a major market for us but an interesting opportunity. We see an increasing global interest for SensoDetect and it's very inspiring and exciting. We want to help all people with mental illness to a better life, and South America are wrestling with the same problems as the rest of the world. The resources are not enough and the queues are growing for the economy and not least the patients, it is important to streamline and SensoDetect constitutes an important element.", says Chairman of the Board, Jan Andersson
VD, SensoDetect Aktiebolag (publ)
Phone: +46 705 424600
Chairman of the board, SensoDetect Aktiebolag (publ)
Phone: +46 793 472280
This information is information that SensoDetect AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on Oktober 4 2017.
SensoDetect highlights through patented equipment brain stem responses to audio stimuli in order to provide health care clear anomalies and patterns for use primarily within psychiatry. The goal is to increase efficiency in Psychiatry and thus the benefits for health care, society, patients and relatives.
Improve the lives of people with mental illness
Making ABR profiling tests with SensoDetect technology an integral part of setting diagnosis for mental illness
Our Value Proposition:
SensoDetect provides a complete audiogram for the brainstem, helping health care professional to set psychiatric diagnoses objectively and cost effectively. This unique offering improves patients’ quality of life and reduces the economic impact on the health care system and society